[go: up one dir, main page]

Follow
Anca Apavaloaei
Anca Apavaloaei
Weill Cornell Medicine
Verified email at med.cornell.edu
Title
Cited by
Cited by
Year
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes
G Ehx, JD Larouche, C Durette, JP Laverdure, L Hesnard, K Vincent, ...
Immunity 54 (4), 737-752. e10, 2021
1212021
The Origin and Immune Recognition of Tumor-Specific Antigens
A Apavaloaei, MP Hardy, P Thibault, C Perreault
Cancers 12 (9), 2607, 2020
892020
Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin
I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ...
Proceedings of the National Academy of Sciences 116 (11), 2019
502019
PSMB11 orchestrates the development of CD4 and CD8 thymocytes via regulation of gene expression in cortical thymic epithelial cells
A Apavaloaei, S Brochu, M Dong, A Rouette, MP Hardy, G Villafano, ...
The Journal of Immunology 202 (3), 966-978, 2019
352019
Breast cancer immunopeptidomes contain numerous shared tumor antigens
E Kina, JP Laverdure, C Durette, J Lanoix, M Courcelles, Q Zhao, ...
The Journal of Clinical Investigation 134 (1), 2024
242024
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, ...
Genome Biology 24 (1), 188, 2023
222023
Induced pluripotent stem cells display a distinct set of MHC I-associated peptides shared by human cancers
A Apavaloaei, L Hesnard, MP Hardy, B Benabdallah, G Ehx, C Thériault, ...
Cell Reports 40 (7), 111241, 2022
202022
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer
A Apavaloaei, Q Zhao, L Hesnard, M Cahuzac, C Durette, JD Larouche, ...
Nature cancer, 1-19, 2025
192025
PSMB11 regulates gene expression in cortical thymic epithelial cells
A Apavaloaei, JP Laverdure, C Perreault
Cell Reports 36 (10), 109546, 2021
72021
Immunotargeting of a recurrent AML-specific neoantigen
A Apavaloaei, C Perreault
Nature Cancer 4 (10), 1403-1405, 2023
32023
BamQuery: a proteogenomic tool for the genome-wide exploration of the immunopeptidome
MV Ruiz Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, ...
bioRxiv, 2022.10. 07.510944, 2022
12022
Psmb11 molds the transcriptome of cortical TECs and CD8 thymocytes
A Apavaloaei, A Rouette, S Brochu, C Perreault
The Journal of Immunology 198 (Supplement_1), 202.14-202.14, 2017
12017
CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling
R Minati, M Cahuzac, J Perrault, V Lullier, A Apavaloaei, E Bonneil, ...
Cell Reports 44 (12), 116676, 2025
2025
1235 Abemaciclib differentially reshapes the immunopeptidome of breast cancer subtypes
R Minati, A Apavaloaei, E Bonneil, M Cahuzac, J Perrault, V Lullier, ...
Journal for ImmunoTherapy of Cancer 13 (Suppl 2), 2025
2025
Novel tumor antigens for lung cancer and uses thereof
C Perreault, P Thibault, MP HARDY, K VINCENT, A APAVALOAEI
2024
–Unmutated tumor antigens are attractive targets for immunotherapy in melanoma and non-small cell lung cancer
A Apavaloaei, Q Zhao, L Hesnard, C Durette, JD Larouche, MP Hardy, ...
Exploring the Landscape of Actionable HLA I-Associated Tumor Antigens Across …, 2023
2023
Exploring the landscape of actionable HLA I-associated tumor antigens across cancers
A Apavaloaei
Université de Montréal, 2023
2023
Unmutated tumor antigens are abundant and contribute to tumor control in melanoma
A Apavaloaei, Q Zhao, L Hesnard, K Vincent, MP Hardy, C Durette, ...
Cancer Research 83 (7_Supplement), 2993-2993, 2023
2023
BamQuery: a new proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
MVR Cuevas, MP Hardy, JD Larouche, A Apavaloaei, E Kina, K Vincent, ...
Cancer Research 83 (7_Supplement), 2987-2987, 2023
2023
Novel tumor-specific antigens for cancer stem cells and uses thereof
C Perreault, P Thibault, MP HARDY, A APAVALOAEI
2023
The system can't perform the operation now. Try again later.
Articles 1–20